schliessen

Filtern

 

Bibliotheken

125.

Editorial Comment
by Campbell, Steven C

The Journal of Urology, 2009, Vol.182(6), pp.2599-2600

131.

Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma
by Rini, Brian I

Clinical cancer research : an official journal of the American Association for Cancer Research, 15 January 2007, Vol.13(2 Pt 2), pp.741s-746s

132.

Randomized phase III trial of temsirolimus and bevacizumab versus interferon alfa and bevacizumab in metastatic renal cell carcinoma: INTORACT trial
by Rini, Brian I

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 10 March 2014, Vol.32(8), pp.752-9

136.

The Evolution of Systemic Therapy in Metastatic Renal Cell Carcinoma.
by Hutson, Thomas E

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2016, Vol.35, pp.113-117

137.

The Evolution of Systemic Therapy in Metastatic Renal Cell Carcinoma
by Hutson, Thomas E.

American Society of Clinical Oncology Educational Book, 05/2016, Issue 36, pp.113-117

138.

Neurophysiological changes: Sunitinib fatigue severity.
by Cunningham, David

Journal of Clinical Oncology, 05/20/2016, Vol.34(15_suppl), pp.e21683-e21683

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 426 Hits